|
Media partners 
We work with leading magazines and publishers in this arena. If you are interested in becoming a media partner for this event please contact:
Nicola Wartnaby, Marketing Director
Email: nicola.wartnaby@terrapinn.com
Tel: +44(0)207 827 5991
Fax: +44(0)207 242 1508
|
Victory over Disease: The Vaccine Fund was created to ensure that all of the world's people - no matter how rich or how poor - have equal access to life-saving vaccines.
The Vaccine Fund was launched in 1999 to address the needs for vaccines and immunizations of the world's 75 poorest countries, those with a per capita GNI of less than $1000. Resources will also be made available for China, India and Indonesia. The Fund provides financing for immunization services and for purchasing new and under-utilized vaccines against diseases such as Hepatitis B, Yellow Fever, and Haemophilus Influenzae-B, a leading cause of childhood meningitis.
To date, more than $1 billion of The Vaccine Fund's resources have been committed to 69 developing country government immunization programs. If these countries are able to achieve their goals, millions more children will be saved over the next five years through outcome-based grants.
Ensuring that every child, everywhere has access to life-saving vaccines.
As a Network of Centres of Excellence, CANVAC, the Canadian Network for Vaccines and Immunotherapeutics, is a unique network of 75 of the most highly recognized Canadian research teams specializing in the fields of immunology, virology, and molecular biology, who are affiliated with 21 Canadian universities and research institutes. CANVAC is working in collaboration with 23 corporate partners, as well as interested government agencies and several patient and consumer groups, towards the development of safe and effective vaccines and immunotherapies to prevent and treat diseases related to HIV and hepatitis C virus, emerging viral infections and cancer. Université de Montréal hosts CANVAC. www.canvac.ca
BIOTECanada is the national association representing the biotechnology industry and research community in Canada. Drawn from a variety of industry sectors, the research community, academia and regional associations, BIOTECanada membership represents approximately 85% of the Canadian biotechnology community. As Canada's voice for biotechnology, BIOTECanada is dedicated to the long term and sustainable development of a Canadian biotechnology industry, its practices and products.
Proudly representing its more than 250 members, BIOQuebec is one the most important networks for bio-industry and health sciences in Canada.
BIOQuebec is committed to supporting the growth and vitality of Quebec’s biotechnology companies. In this vein, it reaches out nationally and internationally to position the Quebec biotechnology community as a center of scientific development and innovation and works collaboratively with partner organizations to fuel growth of the province’s biotech industry.
BIOQuebec’s membership is strengthened by the diversity of company size and the range of industry sub-sectors. Its members are active in the following sectors: Human and animal health, agriculture, bio-food and environment.
Visit us at http://www.bioquebec.com/
The BHRC is a unique organisation that is dedicated to ensuring a greater understanding and management of the human resources issues in the Canadian biotechnology sector. In order to grow Canada's pool of biotech talent, BHRC develops and delivers specialized training, human resource management tools, biotech career information and job portals, acting as the hub of a coast-to-coast network of leading experts in the field of biotechnology.
HPV Today is a newsletter published in English and Spanish which objective is to convey research information to clinicians and offer a comprehensive view of this rapidly evolving field. HPV Today informs on relevant advances in diagnosis, prevention and clinical management of patients as well as conveying the current thinking of the opinion leaders in the field.
D&MD Publications is the leading provider of quality market analysis, opportunity assessment, and tactical guidance filling the ever-changing needs of the life sciences market. We offer a range of strategic publications crucial for pharmaceutical and biotechnology professionals. To order FREE sample content of Vaccines in the 21st Century visit us online at http://www.drugandmarket.com/9150.
A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Request for Quote Outsourcing Services Showcase & Matching Marketplace; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMed Outsourcing Report. Supporting CanBiotech is the consulting division enabling outsourcing of drug discovery and development.
Bio Tech International (BTi) is the only European based publication serving the fields of bioscience and bioindustry. Targetting both the entrepreneurial life science, bioprocessing aswell as the academic research sectors in Europe & Asia/Pacific, BTi is the only magazine in its field with 100% personally requested circulation certified by BPA.
Scrip's Target World Drug Delivery News, is an independent, international news and features information source for the drug delivery sector. Scrip's Target provides you with the information you need to stay up to date with the latest developments in drug delivery - be they new technologies, product and R&D news, company deals, regulatory challenges, patent issues or cutting edge conference reports. For further information please visit www.scripstarget.com or email matthew.holley@informa.com
|
|
|
Gold sponsors
|
|
|
|
|
Silver sponsor
|
|
|
Supporting sponsors
|
|
|
|
|
|
Supported by
|
|
|
Event partners
|
|
|
|
|
|
